112 related articles for article (PubMed ID: 7585038)
1. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease.
Nakao N; Frodl EM; Widner H; Carlson E; Eggerding FA; Epstein CJ; Brundin P
Nat Med; 1995 Mar; 1(3):226-31. PubMed ID: 7585038
[TBL] [Abstract][Full Text] [Related]
2. Radical directions in Parkinson's disease.
Fisher LJ; Gage FH
Nat Med; 1995 Mar; 1(3):201-3. PubMed ID: 7585029
[No Abstract] [Full Text] [Related]
3. Survival and function of aggregate cultures of rat fetal dopamine neurons grafted in a rat model of Parkinson's disease.
Strecker RE; Miao R; Loring JF
Exp Brain Res; 1989; 76(2):315-22. PubMed ID: 2569985
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
5. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
6. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.
Brundin P; Nilsson OG; Strecker RE; Lindvall O; Astedt B; Björklund A
Exp Brain Res; 1986; 65(1):235-40. PubMed ID: 3542544
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase.
Barkats M; Nakao N; Grasbon-Frodl EM; Bilang-Bleuel A; Revah F; Mallet J; Brundin P
Neuroscience; 1997 Jun; 78(3):703-13. PubMed ID: 9153652
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons.
Karlsson J; Emgârd M; Rosenblad C; Brundin P
Brain Res; 1998 Sep; 805(1-2):155-68. PubMed ID: 9733957
[TBL] [Abstract][Full Text] [Related]
9. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
10. Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.
Barkats M; Millecamps S; Bilang-Bleuel A; Mallet J
J Neurochem; 2002 Jul; 82(1):101-9. PubMed ID: 12091470
[TBL] [Abstract][Full Text] [Related]
11. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
Heim RC; Willingham G; Freed WJ
Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
[TBL] [Abstract][Full Text] [Related]
12. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease.
Grealish S; Jönsson ME; Li M; Kirik D; Björklund A; Thompson LH
Brain; 2010 Feb; 133(Pt 2):482-95. PubMed ID: 20123725
[TBL] [Abstract][Full Text] [Related]
13. Increased superoxide dismutase activity improves survival of cultured postnatal midbrain neurons.
Przedborski S; Khan U; Kostic V; Carlson E; Epstein CJ; Sulzer D
J Neurochem; 1996 Oct; 67(4):1383-92. PubMed ID: 8858919
[TBL] [Abstract][Full Text] [Related]
14. Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.
Sziráki I; Mohanakumar KP; Rauhala P; Kim HG; Yeh KJ; Chiueh CC
Neuroscience; 1998 Aug; 85(4):1101-11. PubMed ID: 9681949
[TBL] [Abstract][Full Text] [Related]
15. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease.
Haque NS; Hlavin ML; Fawcett J; Dunnett SB
Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406
[No Abstract] [Full Text] [Related]
16. Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.
Zhang P; Damier P; Hirsch EC; Agid Y; Ceballos-Picot I; Sinet PM; Nicole A; Laurent M; Javoy-Agid F
Neuroscience; 1993 Jul; 55(1):167-75. PubMed ID: 8350985
[TBL] [Abstract][Full Text] [Related]
17. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK
J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136
[TBL] [Abstract][Full Text] [Related]
18. Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Schwarz SC; Sauer H; Oertel WH; Earl CD; Kupsch AR
Exp Brain Res; 1997 Jun; 115(1):71-82. PubMed ID: 9224835
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.
Takayama H; Ray J; Raymon HK; Baird A; Hogg J; Fisher LJ; Gage FH
Nat Med; 1995 Jan; 1(1):53-8. PubMed ID: 7584953
[TBL] [Abstract][Full Text] [Related]
20. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.
Büchele F; Döbrössy M; Hackl C; Jiang W; Papazoglou A; Nikkhah G
Neurobiol Dis; 2014 Aug; 68():112-25. PubMed ID: 24780496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
